SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    B. T. Sy, H. M. Nguyen, N. L. Toan, L. H. Song, H. V. Tong, C. Wolboldt, V. Q. Binh, P. G. Kremsner, T. P. Velavan, C.-T. Bock, Identification of a natural intergenotypic recombinant hepatitis delta virus genotype 1 and 2 in Vietnamese HBsAg-positive patients, Journal of Viral Hepatitis, 2014, 21, 8
  2. 2
    Katja Giersch, Martina Helbig, Tassilo Volz, Lena Allweiss, Lida V. Mancke, Ansgar W. Lohse, Susanne Polywka, Jörg M. Pollok, Jörg Petersen, John Taylor, Maura Dandri, Marc Lütgehetmann, Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infection, Journal of Hepatology, 2014, 60, 3, 538

    CrossRef

  3. 3
    Ingmar Mederacke, Natalie Filmann, Cihan Yurdaydin, Birgit Bremer, Florian Puls, Behrend Johann Zacher, Benjamin Heidrich, Hans Ludger Tillmann, Jens Rosenau, C.-Thomas Bock, Berna Savas, Fabian Helfritz, Frank Lehner, Christian P. Strassburg, Juergen Klempnauer, Karsten Wursthorn, Ulrich Lehmann, Michael P. Manns, Eva Herrmann, Heiner Wedemeyer, Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis delta antigen persistence after liver transplantation, Journal of Hepatology, 2012, 56, 1, 115

    CrossRef

  4. 4
    Heiner Wedemeyer, Svenja Hardtke, Michael P. Manns, Update on the Management of HBV-HDV Coinfection, Current Hepatitis Reports, 2012, 11, 2, 95

    CrossRef

  5. 5
    Stefan G. Hübscher, Andrew D. Clouston, MacSween's Pathology of the Liver, 2012,

    CrossRef

  6. You have free access to this content6
    Stéphanie Pascarella, Francesco Negro, Hepatitis D virus: an update, Liver International, 2011, 31, 1
  7. 7
    Sarah A Hughes, Heiner Wedemeyer, Phillip M Harrison, Hepatitis delta virus, The Lancet, 2011, 378, 9785, 73

    CrossRef

  8. 8
    Kalyan Ram Bhamidimarri, James Park, Douglas Dieterich, Management of Hepatitis B Virus Coinfection: HIV, Hepatitis C Virus, Hepatitis D Virus, Current Hepatitis Reports, 2011, 10, 4, 262

    CrossRef

  9. 9
    Heiner Wedemeyer, Michael P. Manns, Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead, Nature Reviews Gastroenterology & Hepatology, 2010, 7, 1, 31

    CrossRef

  10. 10
    Joel Gozlan, Karine Lacombe, Elyanne Gault, Gilles Raguin, Pierre-Marie Girard, Complete cure of HBV-HDV co-infection after 24weeks of combination therapy with pegylated interferon and ribavirin in a patient co-infected with HBV/HCV/HDV/HIV, Journal of Hepatology, 2009, 50, 2, 432

    CrossRef

  11. 11
    Andrew L Singer, Lauren M Kucirka, Ruth Namuyinga, Colleen Hanrahan, Aruna K Subramanian, Dorry L Segev, The high-risk donor: viral infections in solid organ transplantation, Current Opinion in Organ Transplantation, 2008, 13, 4, 400

    CrossRef

  12. 12
    Elif S. Koytak, Cihan Yurdaydin, Jeffrey S. Glenn, Hepatitis D, Current Treatment Options in Gastroenterology, 2007, 10, 6, 456

    CrossRef

  13. 13
    Swan N. Thung, Histologic findings in recurrent HBV, Liver Transplantation, 2006, 12, S2
  14. 14
    Grazia Anna Niro, Alessia Ciancio, Giovanni Battista Gaeta, Antonina Smedile, Aldo Marrone, Antonella Olivero, Maria Stanzione, Ezio David, Giuseppina Brancaccio, Rosanna Fontana, Francesco Perri, Angelo Andriulli, Mario Rizzetto, Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta, Hepatology, 2006, 44, 3
  15. 15
    G. A. NIRO, A. CIANCIO, H. L. TILLMAN, M. LAGGET, A. OLIVERO, F. PERRI, R. FONTANA, N. LITTLE, F. CAMPBELL, A. SMEDILE, M. P. MANNS, A. ANDRIULLI, M. RIZZETTO, Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study, Alimentary Pharmacology & Therapeutics, 2005, 22, 3
  16. 16
    Robert P. Perrillo, James D. Eason, The use of HBsAg–positive organ donors: Far more than meets the eye?, Liver Transplantation, 2005, 11, 8
  17. 17
    Alessandro Franchello, Valeria Ghisetti, Alfredo Marzano, Renato Romagnoli, Mauro Salizzoni, Transplantation of hepatitis B surface antigen–positive livers into hepatitis B virus–positive recipients and the role of hepatitis delta coinfection, Liver Transplantation, 2005, 11, 8
  18. 18
    Barnabe Dossou Assogba, Byung Hyune Choi, Hyune Mo Rho, Transcriptional activation of the promoter of human cytomegalovirus immediate early gene (CMV-IE) by the hepatitis B viral X protein (HBx) through the NF-κB site, Virus Research, 2002, 84, 1-2, 171

    CrossRef

  19. 19
    J. L. Gerin, Animal Models of Hepatitis Delta Virus Infection and Disease, ILAR Journal, 2001, 42, 2, 103

    CrossRef

  20. 20
    Grazia Anna Niro, Eleonora Gravinese, Elisabetta Martini, Maria Garrubba, Domenico Facciorusso, Pasquale Conoscitore, Giuseppe Di Giorgio, Mario Rizzetto, Angelo Andriulli, Clearance of hepatitis B surface antigen in chronic carriers of hepatitis delta antibodies, Liver, 2001, 21, 4
  21. 21
    Hugo R. Rosen, Paul Martin, VIRAL HEPATITIS IN THE LIVER TRANSPLANT RECIPIENT, Infectious Disease Clinics of North America, 2000, 14, 3, 761

    CrossRef

  22. 22
    Norah A. Terrault, HEPATITIS B VIRUS AND LIVER TRANSPLANTATION, Clinics in Liver Disease, 1999, 3, 2, 389

    CrossRef

  23. 23
    Stephanos J. Hadziyannis, HEPATITIS D, Clinics in Liver Disease, 1999, 3, 2, 309

    CrossRef

  24. 24
    Dong Hoon Lee, Byung Hyune Choi, Hyune Mo Rho, The Synergistic Transactivation of the Hepatitis B Viral (HBV) Pregenomic Promoter by the E6 Protein of Human Papillomavirus Type 16 (HPV-16 E6) with HBV X Protein Was Mediated through the AP1 Site of E Element in the Enhancer I (EnI) in Human Liver Cell, Biochemical and Biophysical Research Communications, 1999, 265, 1, 62

    CrossRef

  25. 25
    John M. Taylor, Hepatitis Delta Virus, Topley and Wilson's Microbiology and Microbial Infections,